To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Rifater® is a fixed dose combination tablet manufactured by Aventis used in the treatment of tuberculosis. Each tablet contains 120 mg rifampicin, 50 mg isoniazid and 300 mg pyrazinamide.
Additional recommended knowledge
It is used in the first two months of tuberculosis treatment. The dose given depends on the patient's weight:
Rifater should not be used in children (the doses are wrong for them).
The purpose of the fixed dose combination is to make it easier for patients to take their medication; but also to ensure that if patients forget to take one or two of their drugs, they do not then develop resistance to the remaining drugs.
Categories: Antibiotics | Sanofi-Aventis
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Rifater". A list of authors is available in Wikipedia.|